RESEARCH TRIANGLE PARK, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (“Opus” or the “Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene ...
Opus Genetics ( ($IRD) ) has shared an update. On December 17, 2025, Viatris Inc., the commercialization partner for Phentolamine Ophthalmic ...
I recently got an iPhone, transitioning from Android. My experience so far has tempted me to yeet this fucking thing into the sun at a significant portion of C, but that is neither here nor there. The ...
Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus' Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback